Senju Pharmaceutical Co., Ltd.

Taiho Pharmaceutical Company Limited

Taisho Pharmaceutical Co., Ltd.

Senju Pharmacuetical Co., Ltd.

Fuminori Tokumochi

Takahiro Ogawa

Kenichi Yoshida

Noriko Saito

Yoshifumi Ikejiri

Hitoshi Ohmori

Shogo Sameshima

Masako Kimura

Motoko Kimura

Atsushi Okumura

Kunihiro Fukushi

Remedy for allergic diseases in the region of the nose

The present invention provides man-made saliva fluids which contain lysozyme chloride in such concentrations as may be able to suppress effectively the development of oral edema and which possess improved feeling of use and show lessened change in appearance and pH value as well as minimized reduction in enzymatic activity of lysozyme chloride after a prolonged period of storage.

Man-made saliva fluids

The present invention provides an anti-allergic pharmaceutical composition for ophthalmic topical administration comprising an IgE antibody production inhibitor as an active ingredient. The present invention also provides a process for producing an anti-allergic pharmaceutical composition for ophthalmic topical administration, which comprises mixing an IgE antibody production inhibitor with a pharmaceutically acceptable carrier, excipient or diluent.

Anti-allergic pharmaceutical composition for ophthalmic topical

There is disclosed an antiallergic composition for ophthalmic or nasal use, comprising cetirizine or a salt thereof as an active ingredient. The antiallergic composition may further contain a cyclodextrin compound, as well as a surfactant and/or a water soluble polymer.

Antiallergic composition for ophthalmic or nasal use

Growing community of inventors

Kobe, Japan

Fuminori Tokumochi